LifeMD (LFMD) Cash & Current Investments (2012 - 2025)

LifeMD (LFMD) has reported Cash & Current Investments for 14 consecutive years, with $37.1 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Cash & Current Investments rose 5.92% year-over-year to $37.1 million; the trailing twelve-month figure through Dec 2025 stood at $37.1 million (up 5.92% YoY), and the FY2025 full-year result was $37.1 million, up 5.92% from the prior year.
• Cash & Current Investments advanced to $37.1 million in Q4 2025 per LFMD's latest filing, from $24.2 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $41.5 million in Q4 2021 and bottomed at $4.1 million in Q4 2022.
• Historically, Cash & Current Investments has averaged $24.1 million across 5 years, with a median of $24.9 million in 2022.
• The sharpest annual moves came in 2021 and 2022: Cash & Current Investments surged 5494.51% in 2021, then tumbled 90.16% in 2022.
• Over 5 years, Cash & Current Investments stood at $41.5 million in 2021, then sank by 90.16% to $4.1 million in 2022, then surged by 723.08% to $33.6 million in 2023, then climbed by 4.2% to $35.0 million in 2024, then rose by 5.92% to $37.1 million in 2025.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $37.1 million, $24.2 million, and $36.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.